92 Results

People

  1. Singer
    Singer
  2. Antonescu
    Antonescu
  3. Dickson
    Dickson
  4. Koff
    Koff
  5. Schwartz
    Schwartz
  6. Tap
    Tap
  7. Agaram
    Agaram
  8. Crago
    Crago
  9. Gounder
    Gounder
  10. Hameed
    Hameed

Groups

  1. Department of Medicine (36)
  2. GSK Faculty (32)
  3. Solid Tumor Oncology Division (31)
  4. Department of Pathology and Laboratory Medicine (25)
  5. Sloan Kettering Institute Faculty (19)
  6. Surgery (18)
  7. Sloan Kettering Institute Postdocs (17)
  8. Breast Medicine Service (16)
  9. Tow Center for Developmental Oncology (TCDO) (16)
  10. Sarcoma Service (11)
  1. "cyclin dependent kinase 4"
Formats
  1. Journal Article (83)
  2. Review (5)
  3. Editorial (2)
  4. Correspondence (1)
  5. Meeting Abstract (1)
Groups
  1. Department of Medicine (36)
  2. GSK Faculty (32)
  3. Solid Tumor Oncology Division (31)
  4. Department of Pathology and Laboratory Medicine (25)
  5. Sloan Kettering Institute Faculty (19)
  6. Surgery (18)

More Groups

People
  1. Samuel Singer (10)
  2. Cristina Antonescu (8)
  3. Andrew Koff (7)
  4. Mark Dickson (7)
  5. Gary Schwartz (5)
  6. William Tap (5)

More People

Years
  1. 2025 (9)
  2. 2024 (16)
  3. 2023 (2)
  4. 2022 (6)
  5. 2021 (4)
  6. 2020 (4)

More Years

Publications
  1. Clinical Cancer Research (7)
  2. Cancer Research (5)
  3. Modern Pathology (4)
  4. Breast Cancer Research and Treatment (3)
  5. Journal of Clinical Oncology (3)
  6. Lancet Oncology (3)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. Elsevier Inc. (8)
  3. Springer (6)
  4. Wiley Blackwell (6)
  5. Cell Press (5)
  6. Nature Publishing Group (5)

More Publishers

Results (92)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Endometrial stromal sarcomas with BCOR internal tandem duplication and variant BCOR/BCORL1 rearrangements resemble high-grade endometrial stromal sarcomas with recurrent CDK4 pathway alterations and MDM2 amplifications
    Journal Article

    Kommoss, F. K. F.; Chiang, S.; Köbel, M.; Koelsche, C.; Chang, K. T. E.; Irving, J. A.; Dickson, B.; Thiryayi, S.; Rouzbahman, M.; Rasty, G.; more...
    American Journal of Surgical Pathology (2022)

    Fulltext@MSK | Save
  • Refining risk stratification in HR-positive/HER2-negative early breast cancer: How to select patients for treatment escalation?
    Review

    Morganti, S.; Marra, A.; Crimini, E.; D’Amico, P.; Zagami, P.; Curigliano, G.
    Breast Cancer Research and Treatment (2022)

    Fulltext@MSK | Save
  • SWI/SNF-deficient undifferentiated malignancies: Where to draw the line
    Editorial

    Tessier-Cloutier, B.; Kleinman, C. L.; Foulkes, W. D.
    Journal of Pathology (2022)

    Fulltext@MSK | Save
  • From DNA copy number gains and tumor dependencies to novel therapeutic targets for high-risk neuroblastoma
    Review

    Decaesteker, B.; Durinck, K.; Van Roy, N.; De Wilde, B.; Van Neste, C.; Van Haver, S.; Roberts, S.; De Preter, K.; Vermeirssen, V.; Speleman, F.
    Journal of Personalized Medicine (2021)

    Fulltext@MSK | Save
  • Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer
    Journal Article

    Wijetunga, N. A.; dos Anjos, C. H.; Zhi, W. I.; Robson, M.; Tsai, C. J.; Yamada, Y.; Dover, L.; Gillespie, E. F.; Xu, A. J.; Yang, J. T.
    Cancer Medicine (2021)

    Fulltext@MSK | Save
  • RETRACTED: Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): One cohort of a phase 2, multicentre, open-label, non-comparative study
    Journal Article

    Rugo, H. S.; Lerebours, F.; Ciruelos, E.; Drullinsky, P.; Ruiz-Borrego, M.; Neven, P.; Park, Y. H.; Prat, A.; Bachelot, T.; Juric, D.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: Evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation
    Journal Article

    Zuco, V.; Pasquali, S.; Tortoreto, M.; Brich, S.; Percio, S.; Dagrada, G. P.; Colombo, C.; Sanfilippo, R.; Lauricella, C.; Gounder, M.; more...
    Journal of Experimental & Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
    Journal Article

    Zhang, Y.; Chen, F.; Fonseca, N. A.; He, Y.; Fujita, M.; Nakagawa, H.; Zhang, Z.; Brazma, A.; PCAWG Transcriptome Working Group; PCAWG Structural Variation Working Group; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells
    Journal Article

    Lamb, D. J.; Rust, A.; Rudisch, A.; Glüxam, T.; Harrer, N.; Machat, H.; Christ, I.; Colbatzky, F.; Wernitznig, A.; Osswald, A.; more...
    Oncotarget (2020)

    Fulltext@MSK | Save
  • Molecular characterization of a rare dedifferentiated liposarcoma with rabdomyosarcomatous differentiation in a 24 year old
    Journal Article

    Olson, N.; Gularte-Mérida, R.; Selenica, P.; Da Cruz Paula, A.; Alemar, B.; Weigelt, B.; Lefferts, J.; Linos, K.
    International Journal of Surgical Pathology (2020)

    Fulltext@MSK | Save